Vitamin E supplementation for reducing cardiovascular events in individuals with DM and the Hp 2-2 genotype

摘要

This invention relates to methods and compositions of determining the benefit of therapy using vitamin-E for the treatment of cardiovascular events in individuals with diabetes melitus based on their Haptoglobin phenotype and the treatment of the cardiovascular events using vitamin-E based on the haptoglobin phenotype.